7 Pillars of Postoperative Atrial Fibrillation Prevention

Abstract

Get full access to this article

View all access options for this article.

References

Ehrlich

MP.

Osorio-Jaramillo

Aref

et al. Atrial fibrillation after cardiac surgery: electrophysiological mechanism and outcome. Ann Thorac Surg 2020; 109: 1765–1772.32061589

Tselentakis

EV.

Woodford

Chandy

et al. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 2006; 135: 68–75.16650868

Kaireviciute

Blann

AD.

Balakrishnan

et al. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost 2010; 104: 122–127.20458440

Zakkar

Ascione

James

et al. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther 2015; 154: 13–20.26116810

Zhang

et al. Relation of mitochondrial DNA copy number in peripheral blood to postoperative atrial fibrillation after isolated off-pump coronary artery bypass grafting. Am J Cardiol 2017; 119: 473–477.27887690

Schneider

Khaliulin

et al. Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: in vitro study in human myocardium. J Thorac Cardiovasc Surg 2005; 129: 41–45.15632823

Lahtinen

Biancari

Salmela

et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 1241–1244.15063244

Lin

M-H.

Kamel

Singer

et al. Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke 2019; 50: 1364–1371.31043148

Villareal

RP.

Hariharan

Liu

et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43: 742–748.14998610

10.

Carter-Storch

Dahl

JS.

Christensen

et al. Postoperative atrial fibrillation after aortic valve replacement is a risk factor for long-term atrial fibrillation. Interact Cardiovasc Thorac Surg 2019; 29: 378–385.30977792

11.

Thorén

Wernroth

M-L.

Christersson

et al. Compared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF. Clin Res Cardiol 2020; 109: 1232–1242.32036429

12.

Echahidi

Pibarot

O’Hara

et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 793–801.18294562

13.

Mariscalco

Biancari

Zanobini

et al. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J Am Heart Assoc 2014; 3: e000752.24663335

14.

Amar

Zhang

Leung

DHY

et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology 2002; 96: 352–356.11818768

15.

Yamashita

Ranjan

et al. Clinical risk factors for postoperative atrial fibrillation among patients after cardiac surgery. Thorac Cardiovasc Surg 2019; 67: 107–116.30071562

16.

Auer

Weber

Berent

et al. Risk factors of postoperative atrial fibrillation after cardiac surgery. J Card Surg 2005; 20: 425–431.16153272

17.

Snir

Vidne

et al. Potential preoperative markers for the risk of developing atrial fibrillation after cardiac surgery. Semin Thorac Cardiovasc Surg 1999; 11: 308–313.10535370

18.

Daoud

EG.

Strickberger

SA.

Man

et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337: 1785–1791.9400034

19.

Mitchell

LB.

Exner

DV.

Wyse

et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA 2005; 294: 3093–3100.16380589

20.

Giri

White

CM.

Dunn

et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 2001; 357: 830–836.11265951

21.

Budeus

Hennersdorf

Perings

et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J 2006; 27: 1584–1591.16760210

22.

Arsenault

KA.

Yusuf

AM.

Crystal

et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing cardiac surgery. Cochrane Database Syst Rev 2013; 2013: CD003611.

23.

Fuster

Rydén

LE.

Cannom

et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27: 1979–2030.16885201

24.

Patti

Chello

Candura

et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 2006; 114: 1455–1461.17000910

25.

Chen

WT.

Krishnan

GM.

Sood

et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg 2010; 140: 364–372.20381820

26.

Wolfrum

Jensen

KS.

Liao

. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003; 23: 729–736.12615672

27.

Freeland

Hamidian Jahromi

Duvall

et al. Postoperative blood transfusion is an independent predictor of acute kidney injury in cardiac surgery patients. J Nephropathol 2015; 4: 121–126.26457259

28.

Thanavaro

Taylor

Vitt

et al. Predictors and outcomes of postoperative respiratory failure after cardiac surgery. J Eval Clin Pract 2020; 26: 1490–1497.31876045

29.

Alameddine

AK.

Visintainer

Alimov

et al. Blood transfusion and the risk of atrial fibrillation after cardiac surgery. J Card Surg 2014; 29: 593–599.24965706

30.

Holmes

SD.

Patel

et al. The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. J Thorac Cardiovasc Surg 2017; 153: 597–605.27938898

31.

Imazio

Brucato

Ferrazzi

et al. Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy. Circulation 2011; 124: 2290–2295.22090167

32.

Imazio

Brucato

Ferrazzi

et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA 2014; 312: 1016–1023.25172965

33.

Lee

JZ.

Singh

Howe

et al. Colchicine for prevention of post-operative atrial fibrillation: a meta-analysis. JACC Clin Electrophysiol 2016; 2: 78–85.29766857

34.

Marik

PE.

Fromm

. The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care 2009; 24: 458–463.19327322

35.

Lancaster

TS.

Schill

MR.

Greenberg

et al. Potassium and magnesium supplementation do not protect against atrial fibrillation after cardiac operation: a time-matched analysis. Ann Thorac Surg 2016; 102: 1181–1188.27596917

36.

Gough

WB.

Zeiler

RH.

Barreca

et al. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol 1982; 4: 375–380.6177932

37.

Saul

JP.

LaPage

. Is it time to tell the emperor he has no clothes?: Intravenous amiodarone for supraventricular arrhythmias in children. Circ Arrhythm Electrophysiol 2010; 3: 115–117.20407103

38.

Lindquist

DE.

Rowe

AS.

Heidel

et al. Evaluation of the hemodynamic effects of intravenous amiodarone formulations during the maintenance phase infusion. Ann Pharmacother 2015; 49: 1317–1321.26416947

39.

Cushing

DJ.

Kowey

PR.

Cooper

et al. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol 2009; 607: 167–172.19232340

40.

Greenberg

MD.

Katz

NM.

Iuliano

et al. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol 2000; 35: 1416–1422.10807441

41.

Archbold

RA.

Schilling

. Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature. Heart 2004; 90: 129–133.14729772

42.

Park

HE.

Kim

K-H.

Kim

K-B

et al. Characteristics of P wave in patients with sinus rhythm after maze operation. J Korean Med Sci 2010; 25: 712–715.20436706

43.

Fleming

GA.

Murray

KT.

et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation 2008; 118: 1619–1625.18824641

44.

Kafkas

NV.

Patsilinakos

SP.

Mertzanos

et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol 2007; 118: 321–325.17049640